Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.1728 | 1 |
Brugia malayi | phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0029 | 0.0043 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0405 | 0.1741 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0029 | 0.0043 | 0.5 |
Trypanosoma brucei | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0108 | 0.1445 | 0.1445 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0124 | 0.1728 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Giardia lamblia | Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit | 0.0029 | 0.0043 | 0.5 |
Mycobacterium leprae | PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) | 0.0108 | 0.1445 | 0.5 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.1728 | 1 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0029 | 0.0043 | 0.5 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Brugia malayi | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Treponema pallidum | diphosphate--fructose-6-phosphate 1-phosphotransferase | 0.0108 | 0.1445 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Echinococcus multilocularis | caspase 2 | 0.0124 | 0.1728 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0029 | 0.0043 | 0.5 |
Echinococcus granulosus | caspase 2 | 0.0124 | 0.1728 | 1 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Trypanosoma cruzi | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0108 | 0.1445 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0405 | 0.1741 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Onchocerca volvulus | 0.0124 | 0.1728 | 0.5 | |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0124 | 0.1728 | 1 |
Brugia malayi | Cell death protein 3 precursor | 0.0124 | 0.1728 | 1 |
Brugia malayi | hypothetical protein | 0.0124 | 0.1728 | 1 |
Mycobacterium tuberculosis | Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) | 0.0108 | 0.1445 | 0.5 |
Trypanosoma brucei | pteridine reductase 1 | 0.0588 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0405 | 0.1741 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0029 | 0.0043 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Brugia malayi | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0029 | 0.0043 | 0.5 |
Mycobacterium ulcerans | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0124 | 0.1728 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0405 | 0.1741 |
Loa Loa (eye worm) | phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.1266 | 0.7115 |
Toxoplasma gondii | phosphofructokinase domain-containing protein | 0.0029 | 0.0043 | 0.5 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0124 | 0.1728 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0092 | 0.1169 | 0.1169 |
Toxoplasma gondii | phosphofructokinase PFKII | 0.0029 | 0.0043 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0108 | 0.1445 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0092 | 0.1169 | 0.6513 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0108 | 0.1445 | 0.8235 |
Toxoplasma gondii | 6-phosphofructokinase | 0.0029 | 0.0043 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0124 | 0.1728 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.25 ug ml-1 | In vitro antibacterial activity against Haemophilus influenzae A 21515 | ChEMBL. | 1992128 |
MIC (functional) | = 0.5 ug ml-1 | In vitro antibacterial activity against Escherichia coli A 15119 | ChEMBL. | 1992128 |
MIC (functional) | = 0.5 ug ml-1 | In vitro antibacterial activity against Enterobacter cloacae A 9656 | ChEMBL. | 1992128 |
MIC (functional) | = 0.5 ug ml-1 | In vitro antibacterial activity against Morganella morganii A 15153 | ChEMBL. | 1992128 |
MIC (functional) | = 0.5 ug ml-1 | In vitro antibacterial activity against Escherichia coli A 15119 | ChEMBL. | 1992128 |
MIC (functional) | = 2 ug ml-1 | In vitro antibacterial activity against Klebsiella pneumoniae A 9664 | ChEMBL. | 1992128 |
MIC (functional) | = 2 ug ml-1 | In vitro antibacterial activity (minimum inhibitory concentration) against Serratia marcescens A 20019. | ChEMBL. | 1992128 |
MIC (functional) | = 4 ug ml-1 | In vitro antibacterial activity against Staphylococcus aureus A 24227 | ChEMBL. | 1992128 |
MIC (functional) | = 4 ug ml-1 | In vitro antibacterial activity (minimum inhibitory concentration, MIC) against Proteus mirabilis A 9900 | ChEMBL. | 1992128 |
MIC (functional) | = 8 ug ml-1 | In vitro antibacterial activity (minimum inhibitory concentration, MIC) against Staphylococcus aureus A 9537. | ChEMBL. | 1992128 |
MIC (functional) | = 8 ug ml-1 | Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration, MIC) against Pseudomonas aeruginosa A 9843 | ChEMBL. | 1992128 |
MIC (functional) | = 16 ug ml-1 | In vitro antibacterial activity against Streptococcus pneumoniae A 9585 | ChEMBL. | 1992128 |
MIC (functional) | = 16 ug ml-1 | In vitro antibacterial activity against Enterococcus faecalis A 9809 | ChEMBL. | 1992128 |
MIC (functional) | = 125 ug ml-1 | Compound was tested in vitro for its antibacterial activity (minimum inhibitory concentration) against Bacteroides fragilis A 22862. | ChEMBL. | 1992128 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.